Browse by Journals

[up]

Group by: Creators | Date | Item Type | Full Text Status | No Grouping

Jump to: H | N | Q | S

Number of items: 6.

H

file

HACKETT, Julia, THORNELOE, Rachael, SIDE, Lucy, WOLF, Michael, HORNE, Rob, CUZICK, Jack and SMITH, Samuel G (2018). Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews. Breast Cancer Research and Treatment, 170 (3), 633-640.

HOLEN, Ingunn, CROSS, Simon S, NEVILLE-WEBBE, Helen L, CROSS, Neil A, BALASUBRAMANIAN, Sabapathy P, CROUCHER, Peter I, EVANS, C Alyson, LIPPITT, Jennifer M, COLEMAN, Robert E and EATON, Colby L (2005). Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo - a role in tumour cell survival? Breast Cancer Research and Treatment, 92 (3), 207-15.

N

NEVILLE-WEBBE, H L, CROSS, N A, EATON, C L, NYAMBO, R, EVANS, C A, COLEMAN, R E and HOLEN, I (2004). Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis. Breast Cancer Research and Treatment, 86 (3), 269-279.

Q

QUAYLE, Lewis, OTTEWELL, Penelope and HOLEN, Ingunn (2018). Therapeutic Resistance and Stemness in Mitotically Quiescent Human Breast Cancer Cells [Abstract only]. Breast Cancer Research and Treatment, 167, 309-405.

QUAYLE, Lewis, OTTEWELL, Penelope and HOLEN, Ingunn (2018). Therapeutic resistance and stemness in mitotically quiescent human breast cancer cells [abstract only]. Breast Cancer Research and Treatment, 167 (1), 393-394.

S

file

SMITH, G., ROBSON, P. and PROBST, Heidi (2016). EP-2078: PROSPECT: Phase 2 rescanning of seromas in patients to evaluate CTV reduction in breast cancer. Breast Cancer Research and Treatment, 119 (Supp1), S980.

This list was generated on Sun Aug 11 17:37:41 2024 UTC.